WITHDRAWN: Smoking cessation for the secondary prevention of coronary heart disease

The Cochrane Database of Systematic Reviews
Julia A Critchley, Simon Capewell

Abstract

Although the importance of smoking as a risk factor for coronary heart disease is beyond doubt, the speed and magnitude of risk reduction when a smoker with coronary heart disease quits are still subjects of debate. To estimate the magnitude of risk reduction when a patient with CHD stops smoking. We searched the Cochrane Register of Controlled Trials (CENTRAL) , MEDLINE, EMBASE, Science Citation Index, CINAHL, PsychLit, Dissertation Abstracts, BIDS ISI Index to Scientific and Technical Proceedings, UK National Research Register from the start of each database. Sixty-one large international cohort studies of cardiovascular disease were identified, and contact made with authors to search for any unpublished results. The search was supplemented by cross-checking references and contact with various experts. Date of last search was April 2003. Any prospective cohort studies of patients with a diagnosis of CHD, which include all-cause mortality as an outcome measure. Smoking status must be measured on at least two occasions to ascertain which smokers have quit, and followed-up for at least two years. Eligibility and trial quality were assessed independently by two reviewers. Twenty studies were included. There was a 36% reduction in...Continue Reading

References

Feb 22, 1975·Lancet·C WilhelmssonL Wilhelmsen
Jul 1, 1979·Journal of the American Academy of Dermatology·W F Lever
Jul 11, 1991·Journal of General Internal Medicine·N A RigottiG E Thibault
Jan 1, 1991·Journal of Clinical Epidemiology·A J DobsonD M Lloyd
Jan 25, 1990·The New England Journal of Medicine·L RosenbergS Shapiro
Jan 30, 1986·The New England Journal of Medicine·A P HallstromR Ray
Jun 1, 1985·American Journal of Epidemiology·S JohanssonA Aberg
Apr 1, 1985·Postgraduate Medical Journal·J Perkins, T B Dick
Sep 1, 1985·Journal of Epidemiology and Community Health·A G ShaperP W Macfarlane
Nov 16, 1973·Deutsche medizinische Wochenschrift·F MatzdorffK Schmidt
May 2, 1969·Deutsche medizinische Wochenschrift·H Gillmann, K Colberg
Aug 1, 1984·Archives of Internal Medicine·R V Ebert, M E McNabb
Nov 23, 1984·JAMA : the Journal of the American Medical Association·C L JajichD H Freeman
Jan 1, 1982·Annual Review of Public Health·L KullerG Weinberg
Jun 4, 1981·The New England Journal of Medicine·G D FriedmanA B Siegelaub
Oct 9, 1995·Archives of Internal Medicine·M Law, J L Tang
Nov 1, 1995·Journal of the American College of Cardiology·R W PetersL Wilhelmsen
Oct 8, 1994·BMJ : British Medical Journal·R DollI Sutherland
Feb 1, 1995·International Journal of Epidemiology·E SigurdssonG Thorgeirsson
Nov 1, 1994·American Journal of Obstetrics and Gynecology·P Dolan-MullenJ Y Groff
Sep 1, 1994·European Heart Journal·E StåhleH E Hansson

❮ Previous
Next ❯

Citations

Jun 5, 2012·Current Treatment Options in Cardiovascular Medicine·Cristina Karohl, Paolo Raggi
Feb 15, 2017·The Cochrane Database of Systematic Reviews·Catherine ChamberlainJoanne E McKenzie
May 8, 2018·The Cochrane Database of Systematic Reviews·Bernadeta BridgwoodPriya Modi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved